Results 151 to 160 of about 28,458 (210)
Data mining results for reduction of adverse drug-drug interaction events in older adults are clinically applicable. [PDF]
Ther Adv Drug SafHunold KM +10 more
europepmc +1 more source
Proton Pump Inhibitor Use and Worsening Kidney Function: A Retrospective Cohort Study Including 122,606 Acid-Suppressing Users. [PDF]
J Gen Intern MedGonzález-Pérez A +5 more
europepmc +1 more source
Wernicke-Korsakoff Syndrome a Rare Complication of Hyperemesis Gravidarum: Case Report. [PDF]
Clin Case RepNeupane A, Shahi A, Adhikari B.
europepmc +1 more source
Efficacy of Omitting H2 Antagonists versus Famotidine in Taxane Hypersensitivity Reactions Prophylaxis: A Randomized, Prospective, Open-Label, Controlled Trial. [PDF]
Asian Pac J Cancer PrevChantharakhit C +3 more
europepmc +1 more source
A 74-year-old man with chronic kidney disease and an increase in serum creatinine from baseline. [PDF]
CMAJBugeja A, Clark EG.
europepmc +1 more source
TRPV4 Promotes Histamine Receptor Signaling in Lymphatic Endothelial Cells
Retamal JS +11 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drug Intelligence & Clinical Pharmacy, 1983
Ranitidine is a selective, competitive histamine H2-receptor antagonist recently approved by the Food and Drug Administration for use in the short-term treatment of active duodenal ulcers and gastric hypersecretory conditions. Ranitidine is four to ten times more potent than cimetidine on a molar basis in inhibiting stimulated gastric acid secretion ...
T S, Gaginella, J H, Bauman
openaire +2 more sources
Ranitidine is a selective, competitive histamine H2-receptor antagonist recently approved by the Food and Drug Administration for use in the short-term treatment of active duodenal ulcers and gastric hypersecretory conditions. Ranitidine is four to ten times more potent than cimetidine on a molar basis in inhibiting stimulated gastric acid secretion ...
T S, Gaginella, J H, Bauman
openaire +2 more sources
Headache: The Journal of Head and Face Pain, 1985
SYNOPSIS Five patients developed severe headaches in close association with the use of ranitidine. Two required hospitalization and three had recurrence of headaches on rechallenge. One had exacerbation of classic migraine. Headaches varied from intermittent and throbbing to steady and continuous, and onset was 12 hours to several ...
C M, Epstein, J, Klopper
openaire +2 more sources
SYNOPSIS Five patients developed severe headaches in close association with the use of ranitidine. Two required hospitalization and three had recurrence of headaches on rechallenge. One had exacerbation of classic migraine. Headaches varied from intermittent and throbbing to steady and continuous, and onset was 12 hours to several ...
C M, Epstein, J, Klopper
openaire +2 more sources
JAMA: The Journal of the American Medical Association, 1983
Ranitidine is an H2-receptor antagonist that was released recently for use in the treatment of acute duodenal ulcer disease, Zollinger-Ellison syndrome, and systemic mastocytosis with gastric hypersecretion. The pharmacokinetics, efficacy, adverse effects, and clinical utility of ranitidine are presented.
openaire +2 more sources
Ranitidine is an H2-receptor antagonist that was released recently for use in the treatment of acute duodenal ulcer disease, Zollinger-Ellison syndrome, and systemic mastocytosis with gastric hypersecretion. The pharmacokinetics, efficacy, adverse effects, and clinical utility of ranitidine are presented.
openaire +2 more sources